Literature for A01.A95: plasmepsin-9
(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Favuzza,P., Palandri,J., de Lera Ruiz,M., Bailey,W., Boyce,C.W., Danziger,A., Fawaz,M.V., Kelly,M., Murgolo,N., Robbins,J.A., Vavrek,M., Zhao,L., Lei,Z., Guo,Z., Reaksudsan,K., Steel,R.W.J., Hodder,A.N., Ngo,A., Dziekan,J.M., Thompson,J.K., Triglia,T., Birkinshaw,R.W., Penington,J.S., Scally,S.W., Dans,M.G., Coyle,R., Sevilleno,N., Orban,A., Feufack-Donfack,L.B., Popovici,J., Lee,M.C.S., Papenfuss,A., Lowes,K.N., Sleebs,B.E., McCarthy,J.S., McCauley,J.A., Boddey,J.A., Olsen,D.B. and Cowman,A.F.
MK-7602: a potent multi-stage dual-targeting antimalarial
EBioMedicine (2025) 123, 106061-106061. PubMed Europe PubMed DOI PMC EPMC I -
Lisauskaite,M., Nixon,G.L., Woodley,C.M., Berry,N.G., Coninckx,A., Qie,L.C., Leung,S.C., Taramelli,D., Basilico,N., Parapini,S., Ward,S.A., Vadas,O., Soldati-Favre,D., Hong,W.D. and O'Neill,P.M.
Design, synthesis and modelling of photoreactive chemical probes for investigating target engagement of plasmepsin IX and X in Plasmodium falciparum
RSC Chem Biol (2024) 5, 19-29. PubMed Europe PubMed DOI PMC EPMC -
de Lera Ruiz,M., Favuzza,P., Guo,Z., Zhao,L., Hu,B., Lei,Z., Zhan,D., Murgolo,N., Boyce,C.W., Vavrek,M., Thompson,J., Ngo,A., Jarman,K.E., Robbins,J., Boddey,J., Sleebs,B.E., Lowes,K.N., Cowman,A.F., Olsen,D.B. and McCauley,J.A.
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria
ACS Med Chem Lett (2022) 13, 1745-1754. PubMed Europe PubMed DOI PMC EPMC I -
Burrows,J.N. and Soldati-Favre,D.
Targeting plasmepsins - an Achilles' Heel of the malaria parasite
Cell Host Microbe (2020) 27, 496-498. PubMed Europe PubMed DOI I -
Cheuka,P.M., Dziwornu,G., Okombo,J. and Chibale,K.
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present)
J Med Chem (2020) 63, 4445-4467. PubMed Europe PubMed DOI -
Favuzza,P., de Lera Ruiz,M., Thompson,J.K., Triglia,T., Ngo,A., Steel,R.W.J., Vavrek,M., Christensen,J., Healer,J., Boyce,C., Guo,Z., Hu,M., Khan,T., Murgolo,N., Zhao,L., Penington,J.S., Reaksudsan,K., Jarman,K., Dietrich,M.H., Richardson,L., Guo,K.Y., Lopaticki,S., Tham,W.H., Rottmann,M., Papenfuss,T., Robbins,J.A., Boddey,J.A., Sleebs,B.E., Sabroux,H.J., McCauley,J.A., Olsen,D.B. and Cowman,A.F.
Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle
Cell Host Microbe (2020) 27, 642-658. PubMed Europe PubMed DOI I -
Munsamy,G., Agoni,C. and Soliman,M.E.S.
A dual target of plasmepsin IX and X: unveiling the atomistic superiority of a core chemical scaffold in malaria therapy
J Cell Biochem (2019) 120, 7876-7887. PubMed Europe PubMed DOI I -
Munsamy,G. and Soliman,M.E.S.
Unveiling a new era in malaria therapeutics: a tailored molecular approach towards the design of plasmepsin IX inhibitors
Protein J (2019) 38, 616-627. PubMed Europe PubMed DOI I -
Mukherjee,B., Tessaro,F., Vahokoski,J., Kursula,I., Marq,J.B., Scapozza,L. and Soldati-Favre,D.
Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases
EMBO J (2018) 37, e98047-e98047. PubMed Europe PubMed DOI I -
Paul,A.S. and Duraisingh,M.T.
Targeting Plasmodium proteases to block malaria parasite escape and entry
Trends Parasitol (2018) 34, 95-97. PubMed Europe PubMed DOI -
Dogga,S.K., Mukherjee,B., Jacot,D., Kockmann,T., Molino,L., Hammoudi,P.M., Hartkoorn,R.C., Hehl,A.B. and Soldati-Favre,D.
A druggable secretory protein maturase of Toxoplasma essential for invasion and egress
elife (2017) 6 PubMed Europe PubMed DOI PMC EPMC -
Pino,P., Caldelari,R., Mukherjee,B., Vahokoski,J., Klages,N., Maco,B., Collins,C.R., Blackman,M.J., Kursula,I., Heussler,V., Brochet,M. and Soldati-Favre,D.
A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress
Science (2017) 358, 522-528. PubMed Europe PubMed DOI I -
Zhao,G., Song,X., Kong,X., Zhang,N., Qu,S., Zhu,W., Yang,Y. and Wang,Q.
Immunization with Toxoplasma gondii aspartic protease 3 increases survival time of infected mice
Acta Trop (2017) 171, 17-23. PubMed Europe PubMed DOI
2025
2024
2022
2020
2019
2018
2017
